Gut Microbiome Dysbiosis in Autoimmune Diseases: Mechanisms, Biomarkers, and Therapeutic Strategies

Sudeep Edpuganti, Krupa Sara Thomas, Divina Mariya Puthooran, Srihitha Mesineni

Abstract


 The gut microbiome plays an important role in the development and progression of autoimmune diseases(AIDS) like rheumatoid arthritis(RA), systemic lupus erythematosus (SLE), type 1 diabetes (T1D), multiple sclerosis (MS), and inflammatory bowel disease (IBD). This narrative review synthesizes the current evidence on how gut dysbiosis contributes to autoimmunity through different mechanisms. Emerging therapeutic strategies targeting the microbiome, which include probiotics, fecal microbiota transplantation(FMT), dietary interventions, and pharmacological modulators, show a promise in restoring microbial balance. while dysbiosis is told as both a cause and consequence of autoimmunity, its exact role still remains complex. Advances in research could shift AID from management of symptoms to prevention and maybe even cure, revolutionizing autoimmune medicine



Keywords


gut microbiome; autoimmunity; dysbiosis

Full Text:

PDF

References


VI. References

Wang, X., Yuan, W., Yang, C., Wang, Z., Zhang, J., Xu, D., Sun, X., & Sun, W. (2024). Emerging role of gut microbiota in autoimmune diseases. Frontiers in immunology, 15, 1365554. https://doi.org/10.3389/fimmu.2024.1365554

Zhang, X., Chen, B. D., Zhao, L. D., & Li, H. (2020). The Gut Microbiota: Emerging Evidence in Autoimmune Diseases. Trends in molecular medicine, 26(9), 862–873. https://doi.org/10.1016/j.molmed.2020.04.001

Gradisteanu Pircalabioru, G., Savu, O., Mihaescu, G., Ovidiu Vrancianu, C., & Chifiriuc, M.-C. (2022). Dysbiosis, Tolerance, and Development of Autoimmune Diseases. IntechOpen. doi: 10.5772/intechopen.104221

Chang, S. H., & Choi, Y. (2023). Gut dysbiosis in autoimmune diseases: Association with mortality. Frontiers in cellular and infection microbiology, 13, 1157918. https://doi.org/10.3389/fcimb.2023.1157918

Zhao, T., Wei, Y., Zhu, Y., Xie, Z., Hai, Q., Li, Z., & Qin, D. (2022). Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities. Frontiers in immunology, 13, 1007165. https://doi.org/10.3389/fimmu.2022.1007165

Li, R., Meng, X., Chen, B., Zhao, L., & Zhang, X. (2021). Gut Microbiota in Lupus: a Butterfly Effect?. Current rheumatology reports, 23(4), 27. https://doi.org/10.1007/s11926-021-00986-z

Shaheen, W. A., Quraishi, M. N., & Iqbal, T. H. (2022). Gut microbiome and autoimmune disorders. Clinical and experimental immunology, 209(2), 161–174. https://doi.org/10.1093/cei/uxac057

Dehner, C., Fine, R., & Kriegel, M. A. (2019). The microbiome in systemic autoimmune disease: mechanistic insights from recent studies. Current opinion in rheumatology, 31(2), 201–207. https://doi.org/10.1097/BOR.0000000000000574

Yao, K., Xie, Y., Wang, J., Lin, Y., Chen, X., & Zhou, T. (2023). Gut microbiota: a newly identified environmental factor in systemic lupus erythematosus. Frontiers in immunology, 14, 1202850. https://doi.org/10.3389/fimmu.2023.1202850

Garabatos, N., & Santamaria, P. (2022). Gut Microbial Antigenic Mimicry in Autoimmunity. Frontiers in immunology, 13, 873607. https://doi.org/10.3389/fimmu.2022.873607

Sawicka-Gutaj, N., Gruszczyński, D., Zawalna, N., Nijakowski, K., Muller, I., Karpiński, T., Salvi, M., & Ruchała, M. (2022). Microbiota Alterations in Patients with Autoimmune Thyroid Diseases: A Systematic Review. International Journal of Molecular Sciences, 23(21), 13450. https://doi.org/10.3390/ijms232113450

Felix, K. M., Tahsin, S., & Wu, H. J. (2018). Host-microbiota interplay in mediating immune disorders. Annals of the New York Academy of Sciences, 1417(1), 57–70. https://doi.org/10.1111/nyas.13508

Heravi, F. S. (2024). Gut microbiota and autoimmune diseases: Mechanisms, treatment, challenges, and future recommendations. Current Clinical Microbiology Reports, 11(1), 18–33. https://doi.org/10.1007/s40588-023-00213-6

Chen, Y., Ma, C., Liu, L., He, J., Zhu, C., Zheng, F., Dai, W., Hong, X., Liu, D., Tang, D., & Dai, Y. (2021). Analysis of gut microbiota and metabolites in patients with rheumatoid arthritis and identification of potential biomarkers. Aging, 13(20), 23689–23701. https://doi.org/10.18632/aging.203641

Del Chierico, F., Rapini, N., Deodati, A., Matteoli, M. C., Cianfarani, S., & Putignani, L. (2022). Pathophysiology of Type 1 diabetes and gut microbiota role. International Journal of Molecular Sciences, 23(23), 14650. https://doi.org/10.3390/ijms232314650

Christovich, A., & Luo, X. M. (2022). Gut microbiota, leaky gut, and autoimmune diseases. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.946248

Buhaș, M. C., Gavrilaș, L. I., Candrea, R., Cătinean, A., Mocan, A., Miere, D., & Tătaru, A. (2022). Gut microbiota in psoriasis. Nutrients, 14(14), 2970. https://doi.org/10.3390/nu14142970

Rosser, E. C., de Gruijter, N. M., & Matei, D. E. (2022). Mini-Review: Gut-Microbiota and the Sex-Bias in Autoimmunity - Lessons Learnt From Animal Models. Frontiers in medicine, 9, 910561. https://doi.org/10.3389/fmed.2022.910561

Wang, T., Sternes, P. R., Guo, X. K., Zhao, H., Xu, C., & Xu, H. (2024). Autoimmune diseases exhibit shared alterations in the gut microbiota. Rheumatology (Oxford, England), 63(3), 856–865. https://doi.org/10.1093/rheumatology/kead364

Kinashi, Y., & Hase, K. (2021). Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity. Frontiers in immunology, 12, 673708. https://doi.org/10.3389/fimmu.2021.673708

Di Vincenzo, F., Del Gaudio, A., Petito, V., Lopetuso, L. R., & Scaldaferri, F. (2023). Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Internal and Emergency Medicine, 19(2), 275–293. https://doi.org/10.1007/s11739-023-03374-w

Yamamoto, E. A., & Jørgensen, T. N. (2020b). Relationships between vitamin D, gut microbiome, and systemic autoimmunity. Frontiers in Immunology, 10. https://doi.org/10.3389/fimmu.2019.03141

Khan, M. F., & Wang, H. (2020). Environmental exposures and autoimmune diseases: contribution of gut microbiome. Frontiers in Immunology, 10. https://doi.org/10.3389/fimmu.2019.03094

Haneishi, Y., Furuya, Y., Hasegawa, M., Picarelli, A., Rossi, M., & Miyamoto, J. (2023). Inflammatory Bowel Diseases and Gut Microbiota. International journal of molecular sciences, 24(4), 3817. https://doi.org/10.3390/ijms24043817

Liu, Y., Alookaran, J. J., & Rhoads, J. M. (2018). Probiotics in Autoimmune and Inflammatory Disorders. Nutrients, 10(10), 1537. https://doi.org/10.3390/nu10101537

Ruzzon, F., & Adami, G. (2024). Environment and arthritis. Clinical and experimental rheumatology, 42(7), 1343–1349. https://doi.org/10.55563/clinexprheumatol/z7lkua

Lin, L., Zhang, K., Xiong, Q., Zhang, J., Cai, B., Huang, Z., Yang, B., Wei, B., Chen, J., & Niu, Q. (2023). Gut microbiota in pre-clinical rheumatoid arthritis: From pathogenesis to preventing progression. Journal of

Autoimmunity, 141,

https://doi.org/10.1016/j.jaut.2023.103001

Zhao, T., Wei, Y., Zhu, Y., Xie, Z., Hai, Q., Li, Z., & Qin, D. (2022b). Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.1007165

Felix, K. M., Tahsin, S., & Wu, H. J. (2018). Host-microbiota interplay in mediating immune disorders. Annals of the New York Academy of Sciences, 1417(1), 57–70.https://doi.org/10.1111/nyas.13508




DOI: http://dx.doi.org/10.52155/ijpsat.v49.2.7105

Refbacks

  • There are currently no refbacks.


Copyright (c) 2025 Sudeep edpuganti, Krupa Sara Thomas, Divina Mariya Puthooran, Srihitha Mesineni

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.